| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ede47b877b6df9c8d0c494cd66f45ae8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
| filingDate |
2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219c760ce9cbdec029a2c71bb96e5ae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d04b15a7c34aecc35c5c6191be9283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d262513b7e1385dff33ab2d929b1e3fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8a32b2174d8dfff22352b53429a5bc |
| publicationDate |
2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101543983-B1 |
| titleOfInvention |
Pharmaceutical composition containing novel histone deacetylase inhibitor for the prevention or treatment of cancer |
| abstract |
The present invention relates to a composition for preventing, improving or treating cancer, which comprises a novel histone deacetylase (HDAC) inhibitor derived from a natural product as an active ingredient. More specifically, the present invention relates to a composition for preventing, The present invention relates to a pharmaceutical composition for preventing or treating cancer and a composition for preventing cancer, which comprises a non-hydroxamate HDAC inhibitor compound 3,5-di-O-caffeoyl quinic acid methyl ester or a pharmaceutically acceptable salt thereof as an active ingredient Or improving health functional food composition. The histone deacetylase inhibitor of the present invention is a natural product-derived compound with little side effects and excellent anticancer effect, and thus can be usefully used for anticancer applications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101766969-B1 |
| priorityDate |
2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |